EP receptor expression in human intestinal epithelium and localization relative to the stem cell zone of the crypts

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Hult, Lene Th ^a   Kleiveland, Charlotte R ^a   Fosnes, Kjetil ^a   Jacobsen, Morten ^a,b   Lea, Tor ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b Østfold Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LABELING; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLON; CRYPT CELL; DUODENUM BIOPSY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; INTESTINE EPITHELIUM; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; STEM CELL;

CYCLOOXYGENASE 1; DINOPROSTONE; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; RNA, MESSENGER; STEM CELLS;

EID: 80055028188     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026816     Document Type: Article

References (45)

1. Stenson WF, (2007) Prostaglandins and epithelial response to injury. Curr Opin Gastroenterol 23: 107-110.
2. Herschman HR, Hall W, (1994) Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer and Metastasis Reviews 13: 241-256.
3. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, et al. (1998) Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073.
4. Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, et al. (2009) Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis. Eur J Pharmacol 603: 120-132.
5. Tessner TG, Cohn SM, Schloemann S, Stenson WF, (1998) Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology 115: 874-882.
6. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, et al. (2006) Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877.
7. Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, et al. (2007) Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 117: 258-269.
8. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, et al. (2002) Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8: 289-293.
9. Wang D, Buchanan FG, Wang H, Dey SK, DuBois RN, (2005) Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Res 65: 1822-1829.
10. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, et al. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809.
11. Sonoshita M, Takaku K, Oshima M, Sugihara K, Taketo MM, (2002) Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res 62: 6846-6849.
12. Cheng H, Leblond CP, (1974) Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat 141: 537-561.
13. Bjerknes M, Cheng H, (1989) Mitotic orientation in three dimensions determined from multiple projections. Biophys J 55: 1011-1015.
14. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, et al. (2007) Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447: 1007-1011.
15. Kleiveland CR, Kassem M, Lea T, (2008) Human mesenchymal stem cell proliferation is regulated by PGE2 through differential activation of cAMP-dependent protein kinase isoforms. Exp Cell Res 314: 1831-1838.
16. Goessling W, North TE, Loewer S, Lord AM, Lee S, et al. (2009) Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136: 1136-1147.
17. Pinto D, Gregorieff A, Begthel H, Clevers H, (2003) Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes & Development 17: 1709-1713.
18. Honda A, Sugimoto Y, Namba T, Watabe A, Irie A, et al. (1993) Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. Journal of Biological Chemistry 268: 7759-7762.
19. Kase M, Houtani T, Sakuma S, Tsutsumi T, Sugimoto T, (2007) Laser microdissection combined with immunohistochemistry on serial thin tissue sections: a method allowing efficient mRNA analysis. Histochem Cell Biol 127: 215-219.
20. Shirahama T, (2000) Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder.Clinical cancer research: an official journal of the American Association for Cancer Research 6: 2424-2430.
21. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012.
22. Kurtin PJ, Pinkus GS, (1985) Leukocyte common antigen--a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. Human pathology 16: 353-365.
23. Michie SA, Spagnolo DV, Dunn KA, Warnke RA, Rouse RV, (1987) A panel approach to the evaluation of the sensitivity and specificity of antibodies for the diagnosis of routinely processed histologically undifferentiated human neoplasms. American journal of clinical pathology 88: 457-462.
24. Torp SH, (1997) Proliferative activity in human glioblastomas: evaluation of different Ki67 equivalent antibodies. Molecular pathology: MP 50: 198-200.
25. Weigmann A, Corbeil D, Hellwig A, Huttner WB, (1997) Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A 94: 12425-12430.
26. Kobari L, Giarratana M-C, Pflumio Fo, Izac B, Coulombel L, et al. (2001) CD133+ Cell Selection Is an Alternative to CD34+ Cell Selection for Ex Vivo Expansion of Hematopoietic Stem Cells. Journal of Hematotherapy & Stem Cell Research 10: 273-281.
27. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
28. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, et al. (2007) Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4. Cell Stem Cell 1: 389-402.
29. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007.
30. van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H, (2009) OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 137: 15-17.
31. Takeuchi K, Tanaka A, Kato S, Amagase K, Satoh H Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Clin Chim Acta 411: 459-466.
32. Cosme R, Lublin D, Takafuji V, Lynch K, Roche JK, (2000) Prostanoids in human colonic mucosa: effects of inflammation on PGE(2) receptor expression. Human immunology 61: 684-696.
33. Halstensen TS, Scott H, Brandtzaeg P, (1990) Human CD8+ intraepithelial T lymphocytes are mainly CD45RA-RB+ and show increased co-expression of CD45R0 in celiac disease. European Journal of Immunology 20: 1825-1830.
34. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, et al. (2009) Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457: 603-607.
35. Montgomery RK, Shivdasani RA, (2009) Prominin1 (CD133) as an Intestinal Stem Cell Marker: Promise and Nuance. Gastroenterology 136: 2051-2054.
36. Potten CS, Owen G, Booth D, (2002) Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci 115: 2381-2388.
37. Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, et al. (2009) Prominin-1/CD133 Marks Stem Cells and Early Progenitors in Mouse Small Intestine. Gastroenterology 136: 2187-2194.e2181.
38. Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, et al. (2009) Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology: 2187-2194 136: 2187-2194e2181.
39. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, et al. (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459: 262-265.
40. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
41. Cohn SM, Schloemann S, Tessner T, Seibert K, Stenson WF, (1997) Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 99: 1367-1379.
42. DuBois RN, Radhika A, Reddy BS, Entingh AJ, (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262.
43. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, et al. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188.
44. Irwin IS, Douglas WK, Suzanne S, Teresa T, Terrence R, et al. (1998) Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306.
45. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, et al. (1999) Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol Cell Physiol 277: C183-201.